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OBSTETRICS
Lactate detection in the brain of growth-restricted
fetuses with magnetic resonance spectroscopy
Irene Cetin, MD, PhD; Barbara Barberis, PhD; Valentina Brusati, MD; Erika Brighina, MD; Luca Mandia, MD;
Andrea Arighi, MD; Tatjana Radaelli, MD; Pietro Biondetti, MD; Nereo Bresolin, MD; Giorgio Pardi, MD;
Mario Rango, MD, PhDlOBJECTIVE: The objective of the study was to determine the feasibility
of detecting fetal brain lactate, a marker of fetal metabolic acidemia,
using a noninvasive technique, proton magnetic resonance spectros-
copy (1H MRS), in intrauterine growth-restricted (IUGR) fetuses.
STUDY DESIGN: In vivo human fetal brain lactate detection was deter-
mined by 1H MRS in 5 fetuses with IUGR. Oxygenation and acid-base
balance data were obtained at birth.
RESULTS: 1H MRS analysis showed the presence of a lactate peak in
the brain of themost severely affected IUGR fetus, with abnormal umbil-
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350.e1 American Journal of Obstetrics& Gynecology OCTOBER 2011ical artery Doppler and fetal heart rate tracing. This finding was consis-
tent with the low oxygen content and high lactic acid concentration ob-
served in umbilical blood obtained at delivery.
CONCLUSION: 1H MRS allows the noninvasive detection of cerebral
actate in IUGR fetuses. Lactate detected by 1H MRS may represent a
possible marker of in utero cerebral injury or underperfusion.
Key words: brain sparing, fetal brain metabolism, fetal distress,
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oManagement and timing of deliveryof intrauterine growth–restricted
(IUGR) fetuses remains a central issue
for obstetricians, because the risk of peri-
natal death has to be balanced with the
cost of prematurity.1,2 Current available
surveillance tests seem to have little impact
on improving long-term neurodevelop-
mental outcome.3,4 Therefore, new mark-
rs of neurological damage should be
ought, based on the understanding of the
daptive processes occurring in the human
etal brain during growth restriction.
Proton magnetic resonance spectros-
opy (1H MRS) is a noninvasive imaging
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Brain 1H MRS identifies several metabo-
lites of biological importance, including
lactate.6 It has been demonstrated that
elevated levels of lactate detected by 1H
RS in the brain of asphyxiated neo-
ates are predictive of neurodevelop-
ental delay.7,8
Plasma lactic acid concentration is in-
deed higher in IUGR fetuses with altered
umbilical arterial Doppler velocimetry and
abnormal fetal heart rate9,10; however, lit-
tle is known about intrauterine changes in
cerebral metabolism in IUGR fetuses.
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bolic profile has been described in utero
in uncomplicated pregnancy by 1H MRS
uring the second and third trimes-
ers.11-14 Such studies have failed to de-
ect lactate in the normal fetal brain.
owever, several authors have recently
uggested that the potential evidence of
erebral lactate is an indicator of altered
etal cerebral metabolism in pathological
onditions.15-17
In this study, we sought to measure fe-
tal cerebral lactate using 1H MRS to eval-
ate whether it could represent a marker
f brain damage in IUGR fetuses.
MATERIALS AND METHODS
Patients were enrolled at the Department
of Mother Neonate and Child “L. Man-
giagalli” of Milano, Italy. Magnetic reso-
nance examinations were performed at the
Magnetic Resonance Spectroscopy Unit
Fondazione IRCCS Ca’ Granda-Ospedale
Maggiore Policlinico, University of Milan,
Milan, Italy. The study was approved by
the Ethical Committee of the Fondazione
IRCCS Ca’ Granda-Ospedale Maggiore
Policlinico, University of Milan, Milan, It-
aly, and written informed consent was ob-ni
sea
t of
eco
ggio
, De
Mi
; ac
inis
f Ne
nda
1 Ptained from all patients.
t
c
t
a
fi
w
t
g
m
p
l
s
t
U
q
c
w
(
t
b
t
t
w
r
w
o
6
(
w
p
www.AJOG.org Obstetrics ResearchStudy population
We studied 5 singleton pregnancies
complicated by IUGR between 28 and 37
weeks of gestation. Gestational age was
calculated from the last menstrual pe-
riod and confirmed by routine ultra-
sonography at 11-12 weeks of gestation.
We identified growth-restricted fe-
tuses in utero through repeated longitu-
dinal measurements that demonstrated a
reduction in fetal growth velocity and
further classified them according to um-
bilical arterial Doppler velocimetry and
fetal heart rate (FHR) tracing.2,10,18 Spe-
cifically, IUGR was defined by measure-
ments of abdominal circumferences be-
low the 10th percentile of reference
values for fetuses of similar ages together
with a shift from the growth curve
greater than 40 centiles.19 As an example,
his represents a decrease from the 50th
entile (measured at 20 weeks) to below
he 10th centile (at the time of IUGR di-
gnosis). Growth restriction was con-
rmed at birth, if the neonatal weight
as below the 10th percentile according
o Italian standards for birth weight and
estational age.20 None of the fetuses
were affected with abnormal karyotype,
genetic syndromes, viral infection, or
major malformations.
Antenatal fetal surveillance was con-
ducted by multivessel arterial and ve-
nous Doppler velocimetry and FHR
evaluation. Doppler waveforms were ob-
tained from uterine arteries, umbilical
artery (UA), middle cerebral artery
(MCA), and ductus venosus. Uterine ar-
teries Doppler velocimetry was consid-
ered altered, if the pulsatility index (PI)
was 2 SDs above the mean for gestational
age on both sides. UA Doppler waveform
was considered abnormal, if the PI was 2
SDs above the mean for gestational age.
End-diastolic velocity was classified as
either present, absent, or reversed. In the
MCA, a PI more than 2 SDs above the
mean for gestational age was defined as
brain sparing, indicating abnormally re-
duced impedance to flow in the cerebral
circulation.21 Ductus venosus velocity
during atrial systole was characterized as
forward or absent/reversed.21
FHR was considered abnormal, if at
least 1 of the following patterns was pres-ent: less than 2 accelerations of the heart
rate to an amplitude of 10 or more beats
per minute lasting 15 seconds or more
during a period of at least 30 minutes;
variability of 5 or fewer beats per minute
during a period of at least 60 minutes;
and U-shaped (late) decelerations in the
heart rate after Braxton Hicks contractions.
IUGR fetuses were classified into 3
groups of increasing clinical severity
based on Doppler velocimetry of the
umbilical artery and FHR as previously
proposed.10 Briefly, type 1 IUGR showed
both normal PI and FHR; type 2 IUGR
had abnormal PI and normal FHR; and
type 3 IUGR showed both abnormal
parameters.
In the IUGR subjects, the concomitant
presence of preeclampsia was defined as
the onset of gestational hypertension
and proteinuria after 20 weeks of gesta-
tion.22 Hypertension was defined as 2 or
ore recordings of a diastolic blood
ressure of 90 mm Hg or more taken at
east 4 hours apart. Proteinuria was con-
idered as the excretion of 300 mg pro-
ein or more over a 24 hour period.22
Preeclampsia was classified as severe, if
1 or more of the following criteria were
present: blood pressure of 160/110 mm
Hg or greater on 2 occasions on bed rest;
proteinuria of 5 g or greater in a 24 hour
urine specimen or 3 or greater on 2 ran-
dom urine samples; oliguria; cerebral or
visual disturbances; pulmonary edema
or cyanosis; epigastric or right upper-
quadrant pain; impaired liver function;
and thrombocytopenia.23
Severe preeclampsia was considered
further complicated by HELLP syn-
drome (hemolysis, elevated liver en-
zymes, and low platelet count) in the
presence of hemolysis (lactate dehydro-
genase 600 U/L), low platelets
(100,000/L), and elevated liver en-
zymes (aspartate aminotransferase 70
/L).24
Timing and route of delivery were
decided based on maternal and/or fetal
parameters, according to our clinical
protocol.
Days of hospitalization in the neonatal
intensive care unit (NICU) and major
neonatal complications were recorded.
OCTOBER 2011 AmericMR procedures
Fetal brainMRI
All magnetic resonance (MR) examina-
tions were performed on an MR system
operating at 1.5 Tesla (Avanto, Siemens,
Germany). No fetal sedation was used.
Body-phased array coils were used in
combination with spinal coils. The stan-
dard MR protocol included gradient-
echo T1-weighted images following the 3
planes of the fetal head and single-shot
T2-weighted images (half-Fourier ac-
quisition, single-shot, turbo spin– echo
[HASTE] sequence). Three-dimensional
T2-weighted images (true fast imaging
with steady precession, True-FISP se-
quence) were also acquired as needed.
Fetal localized brainmagnetic
resonance spectroscopy (MRS)
After the standard MRI protocol, to limit
the time of the procedure as much as
possible, the spectra were acquired with a
single volume of interest (VOI) spin-
echo sequence (PRESS). We located the
VOI in the central brain areas (cerebral
hemispheres; Figure 1), with the VOI
centered on the midline to prevent any
possible inclusion of scalp and extracra-
nial tissues. To limit as much as possible
any potential contamination from adja-
cent lipids during the acquisition of
brain spectra, we ascertained whether
the position of the fetal head was un-
changed at the end of the 1H MRS se-
uence by performing a rapid MRI (lo-
alizer) examination12 to obtain spectra
ith a sufficient signal-to-noise ratio
SNR) in the shortest time possible.
Depending on the size of the fetal brain,
he volume of the voxel was chosen to be
etween 10 and 24 cc to acquire MR spec-
ra with sufficient SNR in a reasonable
ime. Sequences were performed with and
ithout water saturation. The MRS pa-
ameters for the water suppressed spectra
ere as follows: echo time 135 millisec-
nds, repetition time4000 milliseconds,
4 acquisitions. Total acquisition time
imaging and spectroscopy) was limited
ithin 30 minutes in all cases. Data were
rocessed with the use of jMRUI.25 The
jMRUI is a software package used for
the processing of MRS and MRSI data in
the time domain (http://www.mrui.uab.es).
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ing (2048 points), Gaussian filtering (4
Hz), Fourier transformation, and zero-
order phase correction. No baseline cor-
rection was applied. The presence of the
typical lactate signal, visible as an in-
verted doublet at the echo time used, was
searched at 1.33 ppm.
Spectra were normalized to the N-acety-
laspartate (NAA) peak. NAA is well de-
tected and can be unambiguosly identified
by MRS.
Oxygenation and acid-base
balance at birth
Umbilical arterial and venous blood sam-
ples were obtained from a clamped seg-
ment of the cord immediately after deliv-
ery. Blood samples were collected into
heparinized syringes and stored on ice un-
til analyses. Fetal hemoglobin concentra-
tion (Hb), umbilical arterial and venous
oxygen saturation, pH, pO2, pCO2, and
lactate concentration were measured on
a GEM Premier 3000 (Instrumentation
Laboratory, Lexington, MA). Oxygen con-
tent wascalculatedaccordingtotheformula:
2 content (millimoles)  Hb concentra-
ion (grams per liter)  O2 saturation 
0.05982.10
Statistical analysis
Data are presented as mean SD. Anal-
yses were performed using SPSS Statis-
tics Desktop (SPSS, Chicago, IL).
RESULTS
Maternal age ranged between 29 and 35
years (mean, 31.8  2.3 years) and ma-
ternal body mass index between 18 and
22 kg/m2 (mean, 20.4 1.5 kg/m2). Ta-
bles 1 and 2 present the characteristics of
he IUGR population at the time of MRS
tudy and at the time of delivery, respec-
ively. Gestational age at the time of MRS
nd at the time of delivery ranged from
8.2 to 37.0 weeks (mean, 32.6  3.4
eeks) and from 28.5 to 38.5 weeks
mean, 33.5  2.5 weeks), respectively.
ime between MRS and delivery was
-12 days (mean, 5  4 days). Female-
male sex ratio was 4:1.
Antenatal Doppler characteristics of
each single case are presented in Table 1.
Cases 1 and 2 were classified as IUGR
type 1. They presented an abdominal cir-
350.e3 American Journal of Obstetrics& Gynecolocumference between the fifth and 10th
percentile of reference values, normal
Doppler velocimetry in uterine arteries,
umbilical artery, mean cerebral artery
and ductus venosus, and normal FHR.
Fetus 1 had a single umbilical artery and
did not present any major malforma-
tions at birth.
In case 2, the mother was affected by id-
iopathic thrombocythemia (platelet count
approximately 500,000/L), which was
FIGURE 1
Location of the VOI for MRS
he parasagittal T2-weighted image, case 4, is
RS, magnetic resonance spectroscopy; VOI, volume of interest.
etin. Lactate detection in the human fetal brain. Am J Obste
TABLE 1
Gestational age, antenatal Doppler
cases at the time of magnetic reso
IUGR
case no.
GA at
MRS, wks
IUGR
group
Uterine
arteries PI
1 37.0 1 Normal
...................................................................................................................
2 35.3 1 Normal
...................................................................................................................
3 32.6 2 Altered
...................................................................................................................
4 31.3 2 Altered
...................................................................................................................
5 28.2 3 Altered
...................................................................................................................
AEDF, absent-end diastolic flow; AF, amniotic fluid; B.S., br
gestational age; IUGR, intrauterine growth restriction; MCA, m
oligo, oligohydramnios; PEDF, present-end diastolic flow; PI, p
artery.Cetin. Lactate detection in the human fetal brain. Am J Obstet
gy OCTOBER 2011stable during pregnancy. She developed
pregnancy-induced hypertension at 33
weeks of gestational age and was treated
with nifedipine 30 mg per os 3 times a day,
according to our clinical protocol. At 35
weeks’ gestation, she developed mild pro-
teinuria and underwent labour induction
at 35.4 weeks’ gestation. A dinoprostone
vaginal insert was applied and removed 15
hours later because of nonreassuring FHR,
and cesarean section was performed.
wn.
necol 2011.
d fetal heart rate of IUGR
ce spectroscopy
MCA DV AF FHR
rmal Normal Normal Normal Reactive
..................................................................................................................
rmal Normal Normal Normal Reactive
..................................................................................................................
DF B.S. Normal Oligo Reactive
..................................................................................................................
DF B.S. Normal Oligo Reactive
..................................................................................................................
DF B.S. Normal Oligo Altered
..................................................................................................................
paring; DV, ductus venosus; FHR, fetal heart rate; GA,
cerebral artery; MRS, magnetic resonance spectroscopy;
ility index; REDF, reverse-end diastolic flow; UA, umbilicalT sho
M
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www.AJOG.org Obstetrics ResearchCases 3 and 4 were classified as IUGR
type 2. They presented a more severe
growth restriction than the previous
cases (abdominal circumference below
the fifth percentile) with oligohydram-
nios, altered umbilical arterial PI, brain
sparing, and normal FHR. Fetus 3
showed mild cerebral ventriculomegaly
on ultrasound scan (lateral ventricular
size 12 mm), which was confirmed by
standard MRI. Patient 3 developed pre-
eclampsia at 30 weeks and was treated
with nifedipine.
Case 5 was a severe IUGR fetus (IUGR
type 3) with abdominal circumference be-
low the first percentile, oligohydramnios,
and altered umbilical arterial PI and FHR.
The mother was affected by severe pre-
eclampsia, had been treated with nifedi-
pine, and developed the HELLP syn-
drome. Four infants were delivered by
cesarean section without labor for fetal in-
dications, and 1 patient underwent cesar-
ean section after labor induction (case 2).
Data at delivery are presented in Table 2.
No fetal or neonatal deaths occurred. Ox-
TABLE 2
Characteristics of the population a
IUGR case
no.
GA at delivery,
wks Fe
1 38.5 26
...................................................................................................................
2a 35.5 19
...................................................................................................................
3 33.5 13
...................................................................................................................
4 31.5 10
...................................................................................................................
5 28.5 5
...................................................................................................................
F, female; GA, gestational age; IUGR, intrauterine growth rest
a Cesarean section was performed for nonreassuring FHR afte
Cetin. Lactate detection in the human fetal brain. Am J O
TABLE 3
Oxygenation, acid-base balance at
IUGR case
no.
IUGR
group UV pH
1 1 7.34
...................................................................................................................
2 1 7.33
...................................................................................................................
3 2 7.33
...................................................................................................................
4 2 7.36
...................................................................................................................
5 3 7.31
...................................................................................................................
1H MRS, proton magnetic resonance spectroscopy; IUGR, intr
lactate peak absent;, lactate peak present.Cetin. Lactate detection in the human fetal brain. Am J Obstetygenation and acid-base balance data at
delivery are presented in Table 3. Case 5,
the most severe IUGR fetus (IUGR type 3),
presented the lowest oxygen content and
the highest lactic acid concentration at
birth. Lactic acid concentration was also
high at birth in case 4 (IUGR type 2), who
was delivered because of altered FHR, and
in case 2 (IUGR type 1), a fetus with mild
growth restriction who underwent induc-
tion of labor, which affected acid-base bal-
ance at birth.
Case 1 did not require admission to
the NICU. Cases 2 and 3 needed hospi-
talization in the NICU for 10 and 36
days, respectively, but showed no major
neonatal complications. Case 4 experi-
enced respiratory distress syndrome
(RDS) and stayed in the NICU 63 days.
Case 5 had RDS and underwent 2 epi-
sodes of neonatal sepsis. He was dis-
charged from the NICU after 123 days.
MRS studies
In the cases with less severe IUGR (IUGR
types 1 or 2), no lactate peak was detect-
elivery
weight, g
Placental
weight, g Sex
280 F
.........................................................................................................................
350 F
.........................................................................................................................
210 F
.........................................................................................................................
265 F
.........................................................................................................................
100 M
.........................................................................................................................
n; M, male.
or induction (see text).
Gynecol 2011.
livery, and lactate detection by 1H M
pH
UV-O2 cont,
mM
UA-O2 cont,
mM
28 n.a. n.a.
.........................................................................................................................
27 2.3 0.7
.........................................................................................................................
25 2.8 0.3
.........................................................................................................................
28 2.5 0.8
.........................................................................................................................
28 1.2 0.4
.........................................................................................................................
ine growth restriction; Lac, lactate; O2 cont, oxygen content; n.aGynecol 2011.
OCTOBER 2011 Americable (Table 3). In the most severe case
(case 5, IUGR type3), a lactate peak was
clearly visible in the spectrum (Table 3),
as shown in Figure 2.
COMMENT
Principal findings
In this study, we demonstrate a signifi-
cant lactic acid peak in the brain of a se-
verely growth-restricted fetus. In this pa-
tient, MRS was performed at 28 weeks
when reverse flow in the umbilical artery
was evident and FHR was abnormal. We
have previously shown that approxi-
mately 80% of IUGR with these abnor-
malities are associated with hypoxia and
lactacidemia evaluated in utero by fetal
blood sampling.10
Similarly, our case of severe IUGR
showed reduced levels of oxygen content
and increased levels of lactic acid in the
umbilical artery and vein at the time of
delivery (72 hours after MRS) (Table 3).
Moreover, the finding that lactic acid
concentrations were higher in the umbil-
rcentile at
th
Apgar 1
minute
Apgar 5
minute
10 9 10
..................................................................................................................
ss than 5 8 9
..................................................................................................................
ss than 5 8 9
..................................................................................................................
ss than 5 8 9
..................................................................................................................
ss than 5 5 7
..................................................................................................................
in fetal brain
UV lac,
mM
UA lac,
mM
Lac peak at
1H MRS
1.1 1.3 
..................................................................................................................
3.4 3.6 
..................................................................................................................
1.5 1.8 
..................................................................................................................
2.8 3.2 
..................................................................................................................
3.1 3.6 
..................................................................................................................
available; UA, umbilical artery; UV, umbilical venous;,t d
tal
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20 5-
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10 Le
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demonstrates that lactate was produced
by the fetus because of anaerobic metab-
olism, as previously described.9
Our finding is in agreement with 2
previous studies that reported the pres-
ence of lactate by fetal brain MRS in
IUGR fetuses.17,26 Both studies, how-
ever, lack data about oxygenation and
acid-base balance at delivery.
Interestingly, we did not detect any
lactic acid peak in the spectra obtained
by MRS in the other IUGR fetuses stud-
ied, even though we cannot exclude the
presence of cerebral lactate in amounts
below the minimal level of detection of
0.5-1 mM. Although in 2 of these cases
umbilical, as well as cerebral, arterial
Doppler velocimetry was abnormal and
amniotic fluid index was reduced, um-
bilical oxygen and lactate levels were
normal at delivery in 3 of 4 cases in which
brain lactate could not be detected by
MRS. In only 1 case (case 2), umbilical
lactate concentration was high because
of the induction of labor, uterine con-
tractions, and consequent fetal distress,
as indicated by alterations of FHR before
cesarean section was decided. Therefore,
hypoxemia at birth in this case was rea-
sonably acute because of the stress of
labor.
Caution needs to be applied in making
any direct correlation between umbilical
lactate concentration measured at birth
and brain lactate detected by MRS for
several reasons: (1) different intervals of
time elapsed between MRS and birth
(2-12 days); (2) little knowledge about
the mechanisms of lactate transport
through the hematoencephalic barrier
during intrauterine life27; and (3) impos-
ibility of excluding that lactate below the
inimal level of detection of 0.5-1 mM is
resent in the fetal brain. Nevertheless, our
esults indicate that, in hypoxic IUGR fe-
uses with increased lactacidemia because
fanaerobicmetabolism,cerebral lactate is
lso evident.
Detection of lactate in the fetal brain
ay indeed represent an indirect sign of
nergy failure because of reduced aden-
sine-5=-triphosphate production and
itochondrial function impairment.28
In fetal lambs, the degree of cerebral lac-FIGURE 2
Fetal brain lactate detection
The region of the spectra between 1.00 and 2.25 ppm is represented. A, In themost severe IUGR case
(case 5, IUGR type 3), lactate is clearly detectable, because the typical inverted doublet is centered at
1.33 ppm. B, Conversely, no lactate peak is detected in a case of similar gestational age but with a
less severe IUGR (case 4, IUGR type 2). Spectra A and B are normalized to the NAA peak.
IUGR, intrauterine growth restriction; Lac, lactate; NAA, N-acetylaspartate.
Cetin. Lactate detection in the human fetal brain. Am J Obstet Gynecol 2011.tate accumulation studied by MRS is as-
www.AJOG.org Obstetrics Researchsociated with the severity of hypoxic
brain damage.29 Newborn piglets with
IUGR show increased cerebral lactate
during hypoxia, compared with normal-
weight piglets, and this is inversely asso-
ciated with the degree of apoptosis, indi-
cating different cerebral metabolism in
IUGR brain.30
IUGR is a heterogeneous condition,
associated with a specific placental phe-
notype and with different levels of sever-
ity.31 We have previously shown that a
definition of IUGR based on a reduction
of growth rate of the abdominal circum-
ference is able to identify fetuses that expe-
rience a significant reduction in nutrients
delivery and utilization,32,33 although not
invariably hypoxemic and lactacidemic.10
Moreover, whereas redistribution of blood
flows with brain sparing occurs, prelimi-
nary data now suggest that the fetus adapts
to an inadequate environment also with
hypometabolism, reducing oxygen con-
sumption on a per-kilogram basis.34,35
However, failure of these mechanisms
finally occurs and timing of delivery is
still the best option to avoid brain dam-
age, although the identification of this
time point is still a challenge. Moreover,
the ideal marker of brain damage has still
to be identified, because neurostructural
correlations with observed developmen-
tal disabilities have not yet been estab-
lished. We have recently reported a mild
delay in myelination at 40 weeks post-
conceptional age in IUGR that present
brain sparing in utero, with no apparent
brain lesions at MRI.36
Potential limitations
A potential limitation of our study is rep-
resented by the great variability in gesta-
tional age among the IUGR cases. Case 5,
the most severe, was also the most pre-
mature. However, previous MRS studies
have not observed any detectable lactate
peak in the brain of normal fetuses at any
gestational age in the second half of preg-
nancy.12 Nonetheless, we cannot exlude
that lactate is present in the fetal brain at
low and nonsignificant levels and may
act as a fuel also in normal conditions.37
Moreover, the time the MRS and the
umbilical blood sampling can represent
a potential limitation in making direct
correlations between the 2 findings.CONCLUSIONS
We demonstrated the presence of cere-
bral lactate detected in vivo in a severe
IUGR fetus with hypoxia and lactaci-
demia at delivery. Lactate detected by
MRS may therefore, represent a marker
of altered fetal brain metabolism and po-
tential brain damage in IUGR. Further
experimental and clinical investigations
may help to understand the natural his-
tory of IUGR and to evaluate the efficacy
of fetal brain MRS in the clinical
setting. f
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